nach oben

Erschienen in:

01.01.2007 | Case Report

Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders

verfasst von: Vittorio Fineschi, Irene Riezzo, Fabio Centini, Enrico Silingardi, Manuela Licata, Giovanni Beduschi, Steven B. Karch

Erschienen in: International Journal of Legal Medicine | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

We report two cases of sudden cardiac death (SCD) involving previously healthy bodybuilders who were chronic androgenic–anabolic steroids users. In both instances, autopsies, histology of the organs, and toxicologic screening were performed. Our findings support an emerging consensus that the effects of vigorous weight training, combined with anabolic steroid use and increased androgen sensitivity, may predispose these young men to myocardial injury and even SCD.

Sullivan ML, Martinez CM, Gennis P, Gallagher EJ (1998) The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 41:1–15CrossRefPubMed

Delbeke FT, Desmet N, Debackere M (1995) The abuse of doping agents in competing body builders in Flanders (1988–1993). Int J Sports Med 16:66–70PubMed

Scarpino V, Arrigo A, Benzi G, Garattini S, La Vecchia C, Bernardi LR et al (1990) Evaluation of prevalence of “doping” among Italian athletes. Lancet 336:1048–1050CrossRefPubMed

Ferrara SD (2004) Doping antidoping. Piccin, Padua

Melchert RB, Welder AA (1995) Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc 27:1252–1262PubMed

Sheppard M, Davies MJ (1998) Practical cardiovascular pathology. Arnold, London

Karch SB (1998) Drug abuse handbook. CRC, Boca Raton

Schänzer W, Donike M (1993) Metabolism of anabolic steroids in man: synthesis and the use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta 275:23–48CrossRef

Luke JL, Farb A, Virmani R, Sample RHB (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroid: pathological and toxicological findings. J Forensic Sci 35:1441–1447PubMed

10.

Welder AA, Robertson JW, Melchert RB (1995) Toxic effects of anabolic–androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods 33:187–195CrossRefPubMed

11.

Zimmerman HJ, Ishak KG (2002) Hepatic injury due to drugs and toxins. In: MacSween RNM (ed) Pathology of the liver. Churchill Livingstone, London, pp 621–709

12.

Soe KL, Soe M, Gluud CN (1992) Liver pathology associated with the use of anabolic–androgenic steroids. Liver 12:73–79PubMed

13.

Mewis C, Spyridopoulos I, Kuhlkamp V, Seipel L (1996) Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 19:153–155PubMed

14.

Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98:256–261PubMed

15.

Hausmann R, Hammer S, Betz P (1998) Performance enhancing drugs (doping agents) and sudden death—a case report and review of the literature. Int J Leg Med 111:261–264CrossRef

16.

Lyndberg KK (1991) Myokardieinfarkt og ded af bodybuilder behandlet ned anabole steroider. Ugeskr Laeger 153:587–589PubMed

17.

Fineschi V, Baroldi G, Monciotti F, Paglicci Reattelli L, Turillazzi E (2001) Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 125:253–255PubMed

18.

Urhausen A, Hoples R, Kindermann W (1989) One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 58:633–640CrossRef

19.

Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90:496–501CrossRefPubMed

20.

Dickerman RD, Schaller F, Prather I, McConathy WJ (1995) Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology 86:172–173PubMedCrossRef

21.

Baroldi G, Fineschi V, Silver MD, Parolini M, Mittleman RE (2001) Myocardial contraction bands. Definition, quantification and significance. Int J Leg Med 115:142–151CrossRef

22.

Urhausen A, Weller B, Coen B, Kindermann W (1994) Plasma catecholamines during endurance exercise of different intensities as related to individual anaerobic threshold. Eur J Appl Physiol 69:16–20CrossRef

23.

Pomara C, D’Errico S, Riezzo I, de Cillis GP, Fineschi V (2005) Sudden cardiac death in a child affected by Prader–Willi syndrome. Int J Leg Med 119:153–157CrossRef

24.

Bloch W (2002) Anabolic steroids alter cardiac adaptation to exercise. In: Peters C, Schulz T, Michna H (eds) Biomedical side effects of doping. Verlag Sport und Buch Strauß, Köln, pp 51–59

25.

Madea B, Grellner W (1998) Long term cardiovascular effects of anabolic steroids. Lancet 352:33CrossRefPubMed

26.

Hausmann R (2005) Long-term effects of anabolic–androgenic-steroid abuse: morphological findings associated with fatal outcome. In: Tsokos M (ed) Forensic pathology reviews, vol. 2. Humana, Totowa, pp 273–289

Titel: Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders
verfasst von: Vittorio Fineschi
Irene Riezzo
Fabio Centini
Enrico Silingardi
Manuela Licata
Giovanni Beduschi
Steven B. Karch
Publikationsdatum: 01.01.2007
Verlag: Springer-Verlag
Erschienen in: International Journal of Legal Medicine / Ausgabe 1/2007
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI: https://doi.org/10.1007/s00414-005-0055-9

Springer Medizin

Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders

Abstract

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Can post-mortem blood be used for DNA profiling after peri-mortem blood transfusion?

Concerning the paper by Mall et al., entitled ‘Temperature-based death time estimation with only partially environment conditions’ (Int J Legal Med (2005) 119:185–194)

Validation of a DNA-based method for identifying Chrysomyinae (Diptera: Calliphoridae) used in a death investigation

Low volume amplification and sequencing of mitochondrial DNA on a chemically structured chip

δ-Storage pool disease: a pitfall in the forensic investigation of sudden anal blood loss in children: a case report

3-D imaging and quantitative comparison of human dentitions and simulated bite marks

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie